C‑Reactive Protein (CRP) is produced by the liver in response to inflammation.

The high‑sensitivity assay can detect lower concentrations than standard CRP tests.

Clinical uses include:

Assessing risk of cardiovascular disease (CVD).

Detecting low‑grade inflammation associated with atherosclerosis.

Monitoring patients with heart disease, diabetes, or metabolic syndrome.

Supporting evaluation of chronic inflammatory conditions.

Often performed alongside lipid profile tests for comprehensive cardiac risk assessment.

Analyte: Serum hsCRP concentration (mg/L).

Normal Range (varies by lab):

< 1.0 mg/L → Low risk of CVD

1.0–3.0 mg/L → Moderate risk

3.0 mg/L → High risk

Abnormal Findings:

Elevated hsCRP: Suggests increased cardiovascular risk or presence of chronic inflammation.

Very high CRP (>10 mg/L): Usually indicates acute infection or significant inflammation (not for CVD risk assessment).

Clinical Use:

Provides a sensitive marker for cardiovascular risk stratification.

Helps guide preventive and therapeutic interventions.

Supports monitoring of inflammatory status in chronic disease.